Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders

Neurodegenerative disorders are characterized by progressive degeneration of nerve cells resulting in functional decline of cognition and/or movement. As the prevalence of many of these disorders increases with the aging global population, there is an urgent need for disease-modifying drugs that wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Morant, Anne Vinther, Jagalski, Vivien, Vestergaard, Henrik Tang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811601/
https://www.ncbi.nlm.nih.gov/pubmed/31681780
http://dx.doi.org/10.3389/fmed.2019.00223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811601/
https://www.ncbi.nlm.nih.gov/pubmed/31681780
http://dx.doi.org/10.3389/fmed.2019.00223

Ejemplares similares